Crypto Venture Activity Narrows as Investor Participation Hits 6-Year Low
Fewer investors are participating in crypto funding rounds as macroeconomic pressures and competition for capital weigh on venture markets.
Crunchbase AI News·
The week’s largest round was a $650 million financing for electric pickup truck maker Slate Auto. Other sizable investments went to spaces including drug development, autonomous public transit and software engineering.
Read full articleFewer investors are participating in crypto funding rounds as macroeconomic pressures and competition for capital weigh on venture markets.
Nvidia's investment in AI-driven drug discovery could revolutionize biotech, highlighting AI's growing role in diverse industries beyond tech. The post Nvidia invests in Generate Biomedicines, targeting $1.8T market with AI-driven drug discovery appeared first on Crypto Briefing.
Moderna's 13% surge and a 2.5% S&P 500 Healthcare pop test whether biotech can offset an AI chip rout after SOX’s $1T wipeout. Here’s what changed.
This week, most of the largest U.S. startup funding rounds centered around the sector one would suspect: artificial intelligence. Beyond that, the next-biggest area for startup funding was biotech.
The shift to performance-based standards could accelerate innovation in autonomous vehicle design, impacting transportation and business models. The post US Department of Transportation moves to remove brake pedal requirement for driverless vehicles appeared first on Crypto Briefing.
The incident underscores the urgent need for enhanced AI security measures and regulatory scrutiny to protect intellectual property globally. The post Anthropic alleges Alibaba-linked operators targeted Claude’s software engineering capabilities through mass distillation attacks appeared first on Crypto Briefing.
By Daniel Lewis, CEO, LegalOn. Foundation models are improving quickly. One useful measure is software engineering: the length of coding tasks that frontier models can ...
AI-driven drug discovery's rapid progression to human trials could revolutionize biotech timelines, potentially accelerating medical advancements. The post Absci Corporation progresses ABS-201 into human trials, bolstering AI-driven drug discovery appeared first on Crypto Briefing.